Call for the National Boards of Health and the Maritime Administrations to introduce valid screening for type 2 diabetes at the maritime medical examinations
Int Marit Health
.
2023;74(1):70-71.
doi: 10.5603/IMH.2023.0008.
Authors
Olaf Chresten Jensen
1
,
Victoria Corman
2
,
Maria Luisa Canals
3
,
David Lucas
4
,
Ilona Denisenko
5
,
Don Eliseo-Iii Lucero-Prisno
6
,
Helena Estopà Pujol
7
,
Finn Gyntelberg
8
,
Agnes Flores
9
,
Anne-Mette Hedeager Momsen
10
Affiliations
1
Centre for Maritime Health and Society, Department of Public Health, University of Southern Denmark, Esbjerg, Denmark. ocj@health.sdu.dk.
2
Department of Public Health, University of Southern Denmark, Esbjerg, Denmark.
3
University of Cadiz FUECA, Sociedad Española de Medicina Marítima (SEMM)/Sanidad Marítima, Tarragona, Spain.
4
Seafarers' Health Unit, Brest, France.
5
ANO DPO Maritime Medicine, Moscow, Russian Federation.
6
Faculty of Management and Development Studies, University of the Philippines Open University, Los Baños, Laguna, Philippines.
7
Sanidad Marítima (ISM), Barcelona, Spain.
8
National Research Centre for Work Environment, Occupational Medicine Clinic, Bispebjerg, Denmark.
9
Caja Seguro Social, Vacamonte Rep. of Panamá, Panama.
10
Public Health Institute, Klinisk Socialmedicin og Rehabilitering, Aarhus, Denmark.
PMID:
36974495
DOI:
10.5603/IMH.2023.0008
No abstract available
MeSH terms
Diabetes Mellitus, Type 2* / diagnosis
Humans
Naval Medicine*
Ships